BVT Aktienanleihe DB1 28.06.2024/ DE000VU711G9 /
10/06/2024 19:40:33 | Diferencia-0.140 | Bid21:57:18 | Ask10/06/2024 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
100.150EUR | -0.14% | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
DEUTSCHE BOERSE NA O... | 180.00 EUR | 28/06/2024 | Call |
GlobeNewswire
6:00
Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates
Newsfile Corp
5:22
"Winds of Change" Celebrating Kazakhstan's National Parks at The Canvas 3.0 Exhibition June 8th - Ju...
GlobeNewswire
5:16
Northwest China's Yangling setting benchmark for SCO agriculture technology cooperation for shared g...
GlobeNewswire
4:50
Flash News: OKX Announces Participation in Launch of Lagrange Labs' First Production-Ready ZK Prover...
GlobeNewswire
4:19
President Lula to Speak at FII PRIORITY Rio de Janeiro Summit at the Copacabana Palace Wednesday
GlobeNewswire
3:00
AUTODESK ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been F...
GlobeNewswire
3:00
MARINUS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Fi...
GlobeNewswire
2:00
ROSEN, LEADING INVESTOR COUNSEL, Encourages Teladoc Health, Inc. Investors to Secure Counsel Before ...
GlobeNewswire
2:00
ROSEN, A LONGSTANDING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel...
GlobeNewswire
1:19
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Masimo Corporation Investors to Inquire About Securities...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página